Build. Accelerate. Scale.
Advisory for Rare Diseases and Innovative Therapies Across EMEA
Sibarium Life Sciences Advisory helps biotechs and private equity bring transformative therapies and services to complex markets.
From strategy to execution, Sibarium Life Sciences Advisory drives the access and infrastructure that bring breakthrough therapies to patients with rare diseases in need of innovative therapies and other advanced biologics.
We deliver tailored solutions to meet each client’s unique needs.
Core services include:
Developing and executing market entry strategies, including regional and country-specific partnerships
Designing and implementing pricing models, Named Patient Programs (NPPs), and Early Access Programs (EAPs)
Negotiating or optimizing distribution, marketing, and wholesaler agreements
Pressure-testing regional and country specific commercialization strategies
Supporting corporate development initiatives and lead generation
Preparing international and consolidated P&L models
Providing interim executive leadership and management
Board representation
“Plans mean nothing until you’ve reached the patient. Strategy only works if you can execute, adapt, and stay standing when reality hits back.”
Jesse Sibarium
Founder & Strategic Advisor